SCHEMBL3779247

SCHEMBL3779247

O=C(CN1CCN(c2ncc(Br)cn2)CC1)N1CCN(C2CCCC2)CC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.50
KDM4E B2RXH2 4/20 0.50
TDP1 Q9NUW8 1/20 0.50
TP53 P04637 1/20 0.43
MAPT P10636 3/20 0.42
NPSR1 Q6W5P4 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
PARP1 P09874 1/20 0.41
PTPN11 Q06124 1/20 0.40
HTT P42858 1/20 0.40
HRH3 Q9Y5N1 3/20 0.40
PPARG P37231 1/20 0.40
NR2E3 Q9Y5X4 1/20 0.40
NCOR2 Q9Y618 1/20 0.40
SIGMAR1 Q99720 1/20 0.40
PANK3 Q9H999 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3773951 0.89 ALDH1A1 (0.51) ALDH1A1KDM4ETDP1TP53MAPT
SCHEMBL3765950 0.88 ALDH1A1 (0.50) ALDH1A1KDM4ETDP1TP53MAPT
SCHEMBL3780719 0.87 ALDH1A1 (0.51) ALDH1A1KDM4ETDP1TP53MAPT
SCHEMBL13004952 0.87 KDM4E (0.67) ALDH1A1KDM4ETDP1TP53MAPT
SCHEMBL3774019 0.85 ALDH1A1 (0.50) ALDH1A1KDM4ETDP1TP53MEN1
SCHEMBL3776088 0.84 ALDH1A1 (0.48) ALDH1A1KDM4ETDP1TP53MAPT
SCHEMBL3767635 0.83 HRH3 (0.49) ALDH1A1KDM4ETDP1TP53MEN1
SCHEMBL3780648 0.80 MAPT (0.54) ALDH1A1KDM4EMAPTNPSR1MEN1
SCHEMBL3774207 0.80 HRH3 (0.43) ALDH1A1KDM4ETDP1MAPTNPSR1
SCHEMBL3767809 0.79 SIGMAR1 (0.57) ALDH1A1KDM4ESMN1; SMN2PARP1HRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-7851474-B2 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION (US) 2010-12-14 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed
US-20070049571-A1 Dipiperazinyl ketones and related analogues NEUROGEN CORPORATION 2007-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070049571-A1 Dipiperazinyl ketones and related analogues HRH4, HRH3, HRH1 ALDH1A1 1210/4885KDM4E 534/4885TDP1 4483/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.